Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Treace Medical Concepts (TMCI) Asset Writedowns and Impairment (2020 - 2025)

Treace Medical Concepts filings provide 6 years of Asset Writedowns and Impairment readings, the most recent being -$69000.0 for Q3 2025.

  • On a quarterly basis, Asset Writedowns and Impairment fell 139.66% to -$69000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was -$1.9 million, a 169.17% decrease, with the full-year FY2023 number at $400000.0, down 2.68% from a year prior.
  • Asset Writedowns and Impairment hit -$69000.0 in Q3 2025 for Treace Medical Concepts, down from $81000.0 in the prior quarter.
  • In the past five years, Asset Writedowns and Impairment ranged from a high of $2.0 million in Q2 2024 to a low of -$2.4 million in Q4 2024.
  • Median Asset Writedowns and Impairment over the past 5 years was $38000.0 (2023), compared with a mean of $74176.5.
  • The widest YoY moves for Asset Writedowns and Impairment: up 17300.0% in 2024, down 841.74% in 2024.
  • Treace Medical Concepts' Asset Writedowns and Impairment stood at -$35000.0 in 2021, then soared by 1382.86% to $449000.0 in 2022, then decreased by 28.51% to $321000.0 in 2023, then plummeted by 841.74% to -$2.4 million in 2024, then skyrocketed by 97.1% to -$69000.0 in 2025.
  • The last three reported values for Asset Writedowns and Impairment were -$69000.0 (Q3 2025), $81000.0 (Q2 2025), and $500000.0 (Q1 2025) per Business Quant data.